LOPINAVIR AND RITONAVIR
Generic: LOPINAVIR AND RITONAVIR
Camber PharmaceuticalsManufacturer
ORALRoute
LOPINAVIRActive Substance
2021-06-04Original Approval
LOPINAVIR AND RITONAVIR is FDA application ANDA091677, sponsored by HETERO LABS LTD III. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
99 reports
2
NEURODEVELOPMENTAL DISORDER
63 reports
3
DRUG INTERACTION
61 reports
4
IMMUNE RECONSTITUTION SYNDROME
37 reports
5
DRUG EXPOSURE DURING PREGNANCY
30 reports
6
PYREXIA
27 reports
7
VIROLOGIC FAILURE
25 reports
8
DIARRHOEA
21 reports
9
DRUG RESISTANCE
19 reports
10
LIPODYSTROPHY ACQUIRED
18 reports